ARCHIVES

FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA

This article is from The Cancer Letter archive.

Vol. 07 No. 27 | July 3, 1981

Download PDF Visit The Full Archive

Related Articles

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014

Firm To Collaborate With R. W. Johnson On Vaccines.

December 1, 2000

Avastin Loses Indication for Breast Cancer

November 18, 2011

Holland, Hoogstraten Give Up Chairmanships Of CALGB, SWOG

March 6, 1981

HHS Drops Misconduct allegations Against NCI’s Gallo Days Before Appeals Hearing

November 19, 1993

Alternating Mammography, MRI Tested For High-Risk Women

January 30, 2009